Glaucoma is one of the leading causes of irreversible blindness worldwide. An increased intraocular pressure (IOP) is known as major risk factor. Over the last decade several ophthalmic surgical products including novel minimally invasive surgical treatment options and devices for glaucoma have been developed. All these developments aim to cause as little trauma as possible to the eye, to safely, effectively, and sustainably reduce intraocular pressure, to produce reproducible results, and to be easy to adopt. A wide range of ophthalmic surgery systems and micro instruments have applications in ophthalmic surgery in various hospitals and clinics. An intraocular lens (IOL) is a clear, artificial lens implant used to replace a cloudy natural lens in cataract surgery. IOLs also are used for a type of vision correction surgery called refractive lens exchange. Currently, drainage devices that are implanted by means of micro-invasive glaucoma surgery (MIGS) present a promising approach for IOP lowering. (MIGS is gaining more and more interest and popularity. The possible reduction of the number of glaucoma medications, the ab interno approach without damaging the conjunctival tissue, and the probably safer procedures compared to incisional surgical methods.
The global ophthalmic surgical products market segmentation is based on product type (ophthalmic surgical systems, intraocular implants (IOLs), minimally invasive or micro-invasive glaucoma surgery (MIGs) devices, surgical instruments).
The global ophthalmic surgical products market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global ophthalmic surgical products market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global ophthalmic surgical products market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.
Major players operating in the global ophthalmic surgical products market and profiled in this report include Alcon (Novartis), ARC Laser GmbH, Avedro, Inc., Bausch + Lomb, Inc. (Valeant Pharmaceuticals International), Carl Zeiss Meditec AG, ClarVista Medical, Ellex Medical Lasers Ltd., Eye Tech Care, Glaukos Corporation, HOYA Surgical Optics, HumanOptics AG, InnFocus (Santen Pharmaceuticals Co. Ltd.), IRIDEX Corporation, iSTAR Medical, Ivantus, Inc., Johnson & Johnson Vision (J & J), LensGen, Inc., LENSAR, Inc., Lenstec, LIGHTMED, Lumenis, Ltd., NIDEK Co. Ltd., Novartis, Opthec, PhysIOL, Rayner, RxSight, Quantel Medical, PowerVision, STAAR Surgical, Topcon Medical Systems, and Valeant Pharmaceuticals International.